Results 51 to 60 of about 344,924 (336)

Granular Cell Tumor of the Breast: Understanding the Cancer Mimic through a Series of Three Cases

open access: yesIndian Journal of Radiology and Imaging
Granular cell tumors of breast are rare neoplasms, majority of which are benign. Their imaging appearances are often indistinguishable from breast cancer.
Swati Sharma, Aanchal Shah, Smita Sharma
doaj   +1 more source

Issues of breast cancer diagnosis

open access: yesКлинический разбор в общей медицине, 2023
Today, most of patients with malignant neoplasms are patients with breast cancer, BC (18.3% of all malignant neoplasms). The increase in the diagnosis rate of stage I–II BC is observed since 2011: this indicator was 65% in 2011 and 72.5% in 2021 ...
Elena V. Litvyakova   +7 more
doaj   +1 more source

Subpar reporting of pre‐analytical variables in RNA‐focused blood plasma studies

open access: yesMolecular Oncology, EarlyView.
Pre‐analytical variables strongly influence the analysis of extracellular RNA (cell‐free RNA; exRNA) derived from blood plasma. Their reporting is essential to allow interpretation and replication of results. By evaluating 200 exRNA studies, we pinpoint a lack of reporting pre‐analytical variables associated with blood collection, plasma preparation ...
Céleste Van Der Schueren   +16 more
wiley   +1 more source

Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
Cancer‐associated fibroblasts (CAFs) promote cancer growth, invasion (metastasis), and drug resistance. Here, we identified functional and diverse circulating CAFs (cCAFs) in patients with metastatic prostate cancer (mPCa). cCAFs were found in higher numbers and were functional and diverse in mPCa patients versus healthy individuals, suggesting their ...
Richell Booijink   +6 more
wiley   +1 more source

A Misdiagnosis of a Breast Tumor: Histology Solves It

open access: yesGazeta Médica, 2020
A breast lump can be benign or malignant, the late one can be primary or metastatic. When the primary neoplasm is unknown the diagnosis, management and treatment maybe quite difficult.
Nádia Rodrigues Silva   +4 more
doaj   +1 more source

Neoplasm of uncertain behaviour of the breast—a retrospective study in a breast unit [PDF]

open access: yesecancermedicalscience, 2018
Breast lesions include a heterogeneous group of entities with variable clinical behaviour and morphological presentation, mostly classified as benign or malignant, with predictable behaviour. However, there are lesions with clinical, breast imaging and/or biopsy characteristics that do not clarify their nature. These lesions have an uncertain behaviour
Jorge Simões   +6 more
openaire   +2 more sources

Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells

open access: yesMolecular Oncology, EarlyView.
In the era of immunotherapies, many patients either do not respond or eventually develop resistance. We propose to pave the way for proteomic analysis of surface‐expressed proteins called surfaceome, of circulating tumor cells. This approach seeks to identify immune evasion mechanisms and discover potential therapeutic targets. Circulating tumor cells (
Doryan Masmoudi   +3 more
wiley   +1 more source

Metastatic Colonic Adenocarcinoma in Breast: Report of Two Cases and Review of the Literature

open access: yesCase Reports in Oncological Medicine, 2015
Metastatic adenocarcinoma to the breast from an extramammary site is extremely rare. In the literature, the most current estimate is that extramammary metastases account for only 0.43% of all breast malignancies and that, of these extramammary sites ...
Jiten P. Kothadia   +6 more
doaj   +1 more source

Papillary neoplasm of the breast – A review and update

open access: yesHuman Pathology Reports, 2021
Papillary neoplasms of the breast encompass a broad spectrum of lesions that remain one of the most challenging topics in breast pathology. Although recognizing the papillary architecture is straightforward, classification into in situ and invasive can be problematic due to the overlapping features among these lesions. This review focuses on diagnosing
Yihong Wang, Elizabeth C. Song
openaire   +2 more sources

Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression

open access: yesMolecular Oncology, EarlyView.
Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy